Duchnowska, R., Biernat, W., Szostakiewicz, B., Sperinde, J., Piette, F., Haddad, M., Paquet, A., Lie, Y., Czartoryska‐Arłukowicz, B., Wysocki, P., Jankowski, T., Radecka, B., Foszczynska‐Kloda, M., Litwiniuk, M., Dȩbska, S., Weidler, J., Huang, W., Buyse, M., Bates, M., & Jassem, J. (2013). correlation Between Quantitative HER‐2 Protein Expression and Risk for Brain Metastases in HER‐2+ Advanced Breast Cancer Patients Receiving Trastuzumab‐Containing Therapy. Oncologist, 18, 775. http://access.bl.uk/ark:/81055/vdc_100054333947.0x000024